Skip to main content

Table 1 Basic characteristics of subjects

From: Comparison of the efficacy and safety of Shanhuang Jiangzhi tablets and atorvastatin in the treatment of patients with hyperlipidaemia

Variables

Before propensity matching

After propensity matching

Shanhuang

group

n = 372

Atorvastatin

group

n = 691

p-value

Shanhuang group

n = 370

Atorvastatin group

n = 370

p-value

Age, y, mean ± SD

64.5 ± 12.6

62.8 ± 12.2

0.034

64.4 ± 12.6

64.1 ± 11.9

0.706

Males, n (%)

211(56.6)

406(58.8)

0.521

209(56.5)

206(55.7)

0.879

BMI, kg/m2, mean ± SD

25.6 ± 3.7

25.6 ± 2.9

0.857

25.5 ± 3.7

25.3 ± 3.5

0.334

Smoking status, n(%)

91(24.5)

211(30.5)

0.036

91(24.6)

93(25.1)

0.927

Drinking status, n(%)

100(26.9)

204(29.5)

0.363

98(26.5)

102(27.6)

0.804

Hypertension, n(%)

271(72.8)

506(73.2)

0.895

271(73.2)

266(71.9)

0.754

Diabetes mellitus, n(%)

118(31.7)

209(30.2)

0.619

117(31.6)

112(30.3)

0.743

Low EF(< 50%), n(%)

6(1.6)

8(1.2)

0.535

5(1.4)

3(0.8)

0.727

eGFR, ml/min/1.73m2, mean ± SD

91.8 ± 26.8

94.8 ± 27.5

0.089

91.8 ± 26.9

92.2 ± 27.0

0.821

ALT, U/L,mean ± SD

18.3 ± 9.3

18.0 ± 9.4

0.536

18.3 ± 9.3

18.6 ± 9.7

0.742

AST, U/L,mean ± SD

20.0 ± 6.6

20.8 ± 7.1

0.076

20.1 ± 6.6

20.1 ± 7.3

0.903

TC, mmol/L,mean ± SD

5.23 ± 0.89

5.15 ± 0.95

0.168

5.22 ± 0.87

5.22 ± 0.89

0.907

TG, mmol/L,mean ± SD

1.68 ± 1.27

1.88 ± 1.43

0.026

1.64 ± 1.04

1.64 ± 1.04

0.960

LDL-C, mmol/L,mean ± SD

3.55 ± 0.93

3.35 ± 0.94

0.001

3.56 ± 0.92

3.54 ± 0.94

0.725

HDL-C, mmol/L,mean ± SD

1.03 ± 0.23

1.04 ± 0.26

0.583

1.03 ± 0.23

1.02 ± 0.23

0.722

  1. BMI: body mass index; EF: ejection fraction; eGFR:estimated glomerular filtration rate; ALT: alanine aminotransferase; AST:aspartate aminotransferase; TC:total cholesterol; TG:triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol